MA63510A1 - Anticorps se liant spécifiquement à une protéine asm - Google Patents

Anticorps se liant spécifiquement à une protéine asm

Info

Publication number
MA63510A1
MA63510A1 MA63510A MA63510A MA63510A1 MA 63510 A1 MA63510 A1 MA 63510A1 MA 63510 A MA63510 A MA 63510A MA 63510 A MA63510 A MA 63510A MA 63510 A1 MA63510 A1 MA 63510A1
Authority
MA
Morocco
Prior art keywords
asm
protein
bind specifically
antibodies bind
asm protein
Prior art date
Application number
MA63510A
Other languages
English (en)
Inventor
Seung Beom Hong
Mi Rim Hong
Original Assignee
Isu Abxis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isu Abxis Co Ltd filed Critical Isu Abxis Co Ltd
Priority claimed from PCT/KR2022/095105 external-priority patent/WO2022250520A1/fr
Publication of MA63510A1 publication Critical patent/MA63510A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un anticorps se liant spécifiquement à une protéine sphingomyélinase acide (asm). En particulier, l'anticorps ou un fragment de liaison à l'antigène de celui-ci, selon la présente invention, se lie spécifiquement à la protéine asm, avec une affinité de liaison élevée, et, par conséquent, peut être efficacement utilisé pour détecter la protéine asm ou diagnostiquer, etc. Une maladie due à la surexpression de la protéine asm.
MA63510A 2021-05-27 2022-05-26 Anticorps se liant spécifiquement à une protéine asm MA63510A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20210068075 2021-05-27
PCT/KR2022/095105 WO2022250520A1 (fr) 2021-05-27 2022-05-26 Anticorps se liant spécifiquement à une protéine asm

Publications (1)

Publication Number Publication Date
MA63510A1 true MA63510A1 (fr) 2024-03-29

Family

ID=84407083

Family Applications (1)

Application Number Title Priority Date Filing Date
MA63510A MA63510A1 (fr) 2021-05-27 2022-05-26 Anticorps se liant spécifiquement à une protéine asm

Country Status (2)

Country Link
KR (1) KR102738010B1 (fr)
MA (1) MA63510A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102835802B1 (ko) * 2022-11-25 2025-07-22 주식회사 이수앱지스 Asm 단백질에 특이적으로 결합하는 항체
KR20240126916A (ko) * 2023-02-14 2024-08-22 경북대학교 산학협력단 Asm 단백질 또는 이의 단편을 포함하는 퇴행성 신경질환 또는 우울증 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101521117B1 (ko) * 2013-05-07 2015-05-18 경북대학교 산학협력단 Ａｓｍ 억제제를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
KR102738010B1 (ko) 2024-12-04
KR20220160474A (ko) 2022-12-06

Similar Documents

Publication Publication Date Title
Boyer et al. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A− G by mass spectrometry
MA63510A1 (fr) Anticorps se liant spécifiquement à une protéine asm
Bee et al. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product
Kawa et al. A novel immunoglobulin-immunoglobulin interaction in autoimmunity
MA54405B1 (fr) Anticorps de la glycoprotéine de spicule anti-sras-cov-2 et fragments de liaison à l'antigène
MA35345B1 (fr) Proteines de liaisons a un antigene ayant une liaison accrue a fcrn
MA34527B1 (fr) Anticorps contre la metalloproteinase de matrice 9
MA30038B1 (fr) Glycosylation d'anticorps dans la region variable
MA33387B1 (fr) Polypeptides et procede de traitement
ATE478336T1 (de) Immunologische assays und antikörper für das anti-müller-hormon
MA31793B1 (fr) Nouveaux anticorps specifiques de peptides beta- amyloides et leurs utilisations comme agents diagnostiques ou medicaments
EP3859338B1 (fr) Réactif de dosage de l'hémoglobine, kit de dosage et procédé de dosage
AU2002357779A1 (en) Identification of high affinity molecules by limited dilution screening
Boyer et al. High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures
MA34135B1 (fr) Protéines de liaison à un antigène spécifiques pour un composant p de substance amyloïde sérique
Gong et al. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis
ZA202310789B (en) Antibody specifically binding to asm protein
Hirose et al. Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome
FR3109779B1 (fr) Anticorps et ses utilisations
WO2004084841A3 (fr) Nouveaux anticorps d'albumine anti-feline et procedes de detection de maladies renales precoces
Thomson et al. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies
WO2002061435A3 (fr) Vaccins purifies comportant des supermotifs structuraux a2
WO2016046220A1 (fr) Procédé d'analyse d'agrégats dans des échantillons d'anticorps
Rose et al. Ceftiofur sodium: monoclonal antibody development and cross-reactivity studies with structurally related cephalosporins
JP7325334B2 (ja) ヘモグロビンとハプトグロビンとの複合体を安定化する方法、及びヘモグロビンを含む検体を保存するための保存溶液